Gingival crevicular fluid prostaglandin E(2) and thiobarbituric acid reactive substance levels in smokers and non-smokers with chronic periodontitis following phase I periodontal therapy and adjunctive use of flurbiprofen.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

It has been established that smoking is an important risk factor for the initiation and progression of chronic periodontitis (CP). This study investigates the effects of phase I periodontal therapy and adjunctive flurbiprofen administration on prostaglandin E(2) (PGE(2)) and thiobarbituric acid reactive substance (TBARS) levels in gingival crevicular fluid (GCF) samples from smoker and non-smoker patients with CP.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Periodontol.

Title: Journal of periodontology

ISSN: 0022-3492

ISSN (Print): 0022-3492

Publication date (Electronic): Jan 2007

Volume: 78

Issue: 1

Affiliations

[1 ] Department of Periodontology, Faculty of Dentistry, Gazi University, Ankara, Turkey. bulkurtis@yahoo.com

Article

DOI: 10.1902/jop.2007.060217

PubMed ID: 17199546

SO-VID: dff9d4ac-51f5-4388-b87a-63080fd44675

History

Data availability:

Comments

Comment on this article

scite_

Cited by 8

See all cited by